PALFORZIA: payments to doctors
Payments that named PALFORZIA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.2M
- Providers
- 2,421
- Transactions
- 5,765
- Average per transaction
- $204
The per-transaction average — $204 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,421 providers the average total is $486, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Aimmune Therapeutics, Inc. | $892,080 | 75.9% |
| Greer Laboratories, Inc. | $283,360 | 24.1% |
| Nestle Healthcare Nutrition Inc. | $41 | 0.0% |